Back to mobile site

More on CTNM

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+35.5% Growth)
- Ratings (8.3 Score)

Upcoming Events

- Earnings (10/30/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Contineum Therapeutics (NQ:CTNM)
Delayed: 15.49 -0.26 (1.65%)
Prev. Close $15.75  
Open$15.75 
52 Wk High$ 
52 Wk Low$ 
Day High$16.08 
Day Low$14.13 
P/E N/A  
EPS$ 
Volume449,576 


Jul 31, 2026 09:18 AM Contineum Therapeutics, Inc. (CTNM) Tops Q2 EPS by 4c
Jul 31, 2026 08:14 AM Contineum Therapeutics (CTNM) PT Raised to $23 at RBC Capital
Jul 30, 2026 04:11 PM Form 10-Q Contineum Therapeutics, For: Jun 30
Jul 30, 2026 04:08 PM Form 8-K Contineum Therapeutics, For: Jul 30
Jul 30, 2026 04:05 PM Contineum Therapeutics Reports Second-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones
Jul 27, 2026 04:26 PM Form SCHEDULE 13G Contineum Therapeutics, Filed by: BlackRock, Inc.
Jul 17, 2026 05:11 PM Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: MILLENNIUM MANAGEMENT LLC
Jul 13, 2026 04:15 PM Form 8-K Contineum Therapeutics, For: Jul 13
Jul 10, 2026 05:21 PM Form 4 Contineum Therapeutics, For: Jul 08 Filed by: Lorrain Daniel S.
Jul 8, 2026 06:49 PM Form 4 Contineum Therapeutics, For: Jul 08 Filed by: Stengone Carmine N.
View All Articles

Entities mentioned with CTNM

View All Entities